INSIDER TRADING

Aldeyra Therapeutics, Inc. (ALDX) sees insider buying from three insiders: $140,275

By Insider Stock Trader Newsroom1 min readInsider Stock Trader
Aldeyra Therapeutics, Inc. (ALDX) sees insider buying from three insiders: $140,275

The largest purchase: $128,900 by Richard Douglas, a director. Information only, not investment advice.

Form 4 filings show three Aldeyra Therapeutics, Inc. insiders buying stock between Nov 11 and Nov 12, for a total of $140,275.

Richard Douglas (director) made the largest purchase, $128,900 at an average of $0.6445 a share. Three or more insiders buying within 14 days is what Insider Stock Trader labels a cluster buy.

Every purchase was an open-market trade (transaction code P) of common stock, and none is marked as part of a 10b5-1 plan. The table below lists who bought, when, and at what price.

Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.

Who bought when
InsiderRoleTrade dateSharesAvg. priceValueFiling
Richard DouglasDirectorNov 11200,000$0.6445$128,900App · SEC
Michael AlfieriPrincipal Financial OfficerNov 1110,000$0.6500$6,500App · SEC
Darlene M Deptula-HicksDirectorNov 127,500$0.6500$4,875App · SEC
Total$140,275

Each row of the table links to its Form 4 on SEC.gov.

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.